A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2007

Conditions
HIV Infection
Interventions
DRUG

No Intervention -- Observational study

Trial Locations (25)

1000

GSK Investigational Site, Brussels

GSK Investigational Site, Ljubljana

1070

GSK Investigational Site, Brussels

20025

GSK Investigational Site, Legnano (MI

20142

GSK Investigational Site, Milan

28041

GSK Investigational Site, Madrid

28805

GSK Investigational Site, Alcalá de Henares

29020

GSK Investigational Site, Málaga

35128

GSK Investigational Site, Padua

39100

GSK Investigational Site, Bolzano

46015

GSK Investigational Site, Valencia

47900

GSK Investigational Site, Rimini

302040

GSK Investigational Site, Oryol

308036

GSK Investigational Site, Belgorod

400040

GSK Investigational Site, Volgograd

A-8020

GSK Investigational Site, Graz

A-6020

GSK Investigational Site, Innsbruck

A-5020

GSK Investigational Site, Salzburg

A-1090

GSK Investigational Site, Vienna

A-1140

GSK Investigational Site, Vienna

00185

GSK Investigational Site, Rome

03010

GSK Investigational Site, Alicante

08916

GSK Investigational Site, Badalona

08907

GSK Investigational Site, Barcelona

CH 2301

GSK Investigational Site, La Chaux-de-Fonds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY